Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 162,600
Avg Vol 138,340
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 12%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Avant Technologies Inc. develops, acquires, and creates artificial intelligence (AI) technologies. The company publishes Thy News application for processing news from various sources. It also provides information technology (IT) consulting services, including project management and software administration, financial and asset management, service management, and event management. In addition, the company provides full-stack software development, database management, data integration, project mana...

Industry: Software - Application
Sector: Technology
Phone: 866 533 0065
Fax: 702 872 2060
Address:
5348 Vegas Drive, Las Vegas, United States
BiggNasty
BiggNasty Jul. 7 at 2:56 PM
$HCTI I’m checking all of these out $TEM, $AVAI $OABI
1 · Reply
Hanzo_Hasashi
Hanzo_Hasashi Jul. 2 at 4:07 PM
$AVAI - another 10-K NT filing. Can’t file on time to save their lives. notice the insiders are loaning the company money then taking millions of shares to forgive the loans. classic p&d stock
1 · Reply
Awiz2
Awiz2 Jul. 2 at 11:52 AM
$AVAI It would be a perfect time for a short squeeze here!!!!
1 · Reply
LewisDaKat
LewisDaKat Jul. 1 at 12:25 AM
News Avant Technologies and JV Partner, Ainnova, Prepare for Key FDA Milestone with Next Week's Pre-Submission Meeting https://marketwirenews.com/news-releases/avant-technologies-and-jv-partner-ainnova-prepare-fo-7404288910140541.html $AVAI
0 · Reply
resx18
resx18 Jun. 27 at 6:03 PM
0 · Reply
Awiz2
Awiz2 Jun. 27 at 3:20 PM
$AVAI Thats good news!
0 · Reply
resx18
resx18 Jun. 27 at 1:09 PM
$AVAI Avant Technologies (OTCQB: AVAI) withdrew its currently pending Form S-1 Termination of a Material Definitive Agreement The Company withdrew its currently pending Form S-1 registration statement and pursue a revised equity financing structure with improved terms, including a higher minimum floor price of $2 per share. This new structure will be designed to better reflect prevailing market conditions, enhance compliance with applicable regulations, and support transparent corporate governance. https://www.otcmarkets.com/filing/html?id=18457568&guid=Pdi-kp4gOAIqJth
0 · Reply
CameoBrien
CameoBrien Jun. 27 at 1:08 PM
$AVAI Focused on AI and healthcare tech: IT consulting, AI-enabled health products (e.g., Thy News app, healthcare AI platform) Engaged in key partnerships and projects: Formed a joint venture with Ainnova for diabetic retinopathy screening, vision-AI, dementia detection & automated retinal cameras Signed a Letter of Intent on June 10, 2025, and expanding Latin American reach
0 · Reply
resx18
resx18 Jun. 27 at 1:00 PM
0 · Reply
CameoBrien
CameoBrien Jun. 27 at 11:14 AM
$AVAI 🌞
0 · Reply
Latest News on AVAI
No data available.
BiggNasty
BiggNasty Jul. 7 at 2:56 PM
$HCTI I’m checking all of these out $TEM, $AVAI $OABI
1 · Reply
Hanzo_Hasashi
Hanzo_Hasashi Jul. 2 at 4:07 PM
$AVAI - another 10-K NT filing. Can’t file on time to save their lives. notice the insiders are loaning the company money then taking millions of shares to forgive the loans. classic p&d stock
1 · Reply
Awiz2
Awiz2 Jul. 2 at 11:52 AM
$AVAI It would be a perfect time for a short squeeze here!!!!
1 · Reply
LewisDaKat
LewisDaKat Jul. 1 at 12:25 AM
News Avant Technologies and JV Partner, Ainnova, Prepare for Key FDA Milestone with Next Week's Pre-Submission Meeting https://marketwirenews.com/news-releases/avant-technologies-and-jv-partner-ainnova-prepare-fo-7404288910140541.html $AVAI
0 · Reply
resx18
resx18 Jun. 27 at 6:03 PM
0 · Reply
Awiz2
Awiz2 Jun. 27 at 3:20 PM
$AVAI Thats good news!
0 · Reply
resx18
resx18 Jun. 27 at 1:09 PM
$AVAI Avant Technologies (OTCQB: AVAI) withdrew its currently pending Form S-1 Termination of a Material Definitive Agreement The Company withdrew its currently pending Form S-1 registration statement and pursue a revised equity financing structure with improved terms, including a higher minimum floor price of $2 per share. This new structure will be designed to better reflect prevailing market conditions, enhance compliance with applicable regulations, and support transparent corporate governance. https://www.otcmarkets.com/filing/html?id=18457568&guid=Pdi-kp4gOAIqJth
0 · Reply
CameoBrien
CameoBrien Jun. 27 at 1:08 PM
$AVAI Focused on AI and healthcare tech: IT consulting, AI-enabled health products (e.g., Thy News app, healthcare AI platform) Engaged in key partnerships and projects: Formed a joint venture with Ainnova for diabetic retinopathy screening, vision-AI, dementia detection & automated retinal cameras Signed a Letter of Intent on June 10, 2025, and expanding Latin American reach
0 · Reply
resx18
resx18 Jun. 27 at 1:00 PM
0 · Reply
CameoBrien
CameoBrien Jun. 27 at 11:14 AM
$AVAI 🌞
0 · Reply
CameoBrien
CameoBrien Jun. 26 at 7:06 PM
0 · Reply
resx18
resx18 Jun. 26 at 3:52 PM
0 · Reply
CameoBrien
CameoBrien Jun. 26 at 1:41 PM
0 · Reply
resx18
resx18 Jun. 26 at 1:00 PM
$AVAI https://www.reddit.com/r/wallstreet/comments/1lkyect/avai_avant_technologies_creating_new_company_for/
0 · Reply
jParkz
jParkz Jun. 26 at 12:39 PM
$AVAI news source: https://marketwirenews.com/news-releases/avant-technologies-jv-partner-ainnova-begins-diabeti-4550409988512903.html
0 · Reply
jParkz
jParkz Jun. 26 at 12:26 PM
$AVAI LFG todays the day
0 · Reply
resx18
resx18 Jun. 26 at 12:13 PM
$AVAI Good Morning
0 · Reply
CameoBrien
CameoBrien Jun. 26 at 11:37 AM
$AVAI 🌞
0 · Reply
CameoBrien
CameoBrien Jun. 25 at 7:32 PM
0 · Reply
CameoBrien
CameoBrien Jun. 25 at 3:39 PM
$AVAI nice start
0 · Reply
resx18
resx18 Jun. 25 at 3:27 PM
0 · Reply
resx18
resx18 Jun. 25 at 2:50 PM
$AVAI Avant Technologies (OTCQB: $AVAI) is making bold moves to redefine diabetes management, from early detection with Vision AI to potential treatments through its new company. With a scalable platform, strategic partnerships, and a clear vision for growth, AVAI is an under-the-radar stock with breakout potential. Investors looking for exposure to AI and biotech innovation should keep AVAI on their radar.
0 · Reply